TAKE THIS POLL |
|
|
- Closing Glance: Biotechnology slip 17 May 2008 04:40 GMT
... down $1.71, or 2.8 percent, at $59.29. Amgen Inc., down 15 cents to $42.05. Biogen Idec Inc., up 55 cents to $62.90. Genentech Inc., down 43 cents to $68.83. ...
- Icahn bought 6.3 mln Amylin shares in Q1: filing 16 May 2008 20:07 GMT
... (AMLN.O: ) in the first quarter of 2008 and also boosted his stake in Biogen Idec Inc (BIIB.O: ) during that time period, according to documents Icahn filed with ...
- UPDATE 1-Icahn bought 6.3 mln Amylin shares in Q1 - filing 16 May 2008 19:30 GMT
... (AMLN.O: ) in the first quarter of 2008 and also boosted his stake in Biogen Idec Inc (BIIB.O: ) during that time period, according to documents Icahn filed with ...
- Rumor Mill: Pfizer Buying MediGene? 16 May 2008 17:24 GMT
... mentioned in the same sentence as Pfizer in the last few months (others include Biogen, Shire, King and NicOx). In the past year, many analysts have urged Pfizer to ...
- Icahn buys 6.3 mln shares of Amylin 16 May 2008 16:13 GMT
... (AMLN.O: ) in the first quarter of 2008 and also boosted his stake in Biogen Idec Inc (BIIB.O: ) during that time period, according to documents Icahn filed with ...
- Icahn Capital drops CSX, Macy's, Unum and Take-Two 16 May 2008 13:34 GMT
... Cmn 14,775,468 1,197,308 Applera Corp. Cmn 649,026 0 BEA Systems Inc. Cmn 41,456,016 0 Biogen Idec Inc. Cmn 9,948,723 1,692,000 Blockbuster Inc. Cl A 10,523,840 0 Blockbuster Inc. Cl ...
- Icahn targets Yahoo's board 16 May 2008 11:31 GMT
... contest resulted in a spinoff or a share buyback. Two proxy contests are continuing: Biogen Idec Inc. and Yahoo. In the remaining contests, he lost or withdrew. "This is ...
- Icahn launches bid to take Yahoo board 16 May 2008 07:59 GMT
... contest resulted in a spinoff or a share buyback. Two proxy contests are continuing: Biogen Idec Inc. and Yahoo. In the remaining contests, he lost or withdrew. "This is ...
- Carl Icahn's proxy fights 16 May 2008 07:52 GMT
... seats won Icahn dropped a lawsuit against the company and increased his investment stake Biogen Idec 2008 Goal: 3 board seats Result: ? ...
- ZymoGenetics Announces Publication of Five IL-21 ASCO Abstracts 16 May 2008 01:15 GMT
... Bayer HealthCare Pharmaceuticals, Inc. Rituxan(R) (rituximab) is a registered trademark of Genentech, Inc. and Biogen Idec Inc. ZymoGenetics, Inc. Susan W. Specht, MBA, Director, Corporate Communications 206-442-6592 or Michael ...
- Icahn holds stake in Amylin, drops Macy's and CSX 16 May 2008 00:17 GMT
... said the price is too low. The investor also reported boosting his stakes in Biogen Idec Inc., Enzon Pharmaceuticals Inc., Forestar Real Estate Group Inc., Guaranty Financial Group Inc. ...
- Billionaire Carl Icahn to run board slate for Yahoo! 15 May 2008 23:30 GMT
... and earlier this month, he nominated three candidates to the board of biotech company Biogen Idec Inc. Hedge fund managers had mixed views about the Icahn move. "You can't ...
- Icahn holds stake in Amylin, cut Macy's and CSX 15 May 2008 22:33 GMT
... said the price is too low. The investor also reported boosting his stakes in Biogen Idec Inc., Enzon Pharmaceuticals Inc., Forestar Real Estate Group Inc., Guaranty Financial Group Inc. ...
- 'Giant stomach' plans approved 15 May 2008 13:11 GMT
... to power 2,000 homes a year is to be built. Controversial plans, submitted by Biogen, will see the building of the recycling plant at Higham Park Farm site, off ...
- Icahn to run board slate for Yahoo: sources 15 May 2008 13:07 GMT
... and earlier this month, he nominated three candidates to the board of biotech company Biogen Idec Inc Hedge fund managers had mixed views about the Icahn move. "You can't ...
- Icahn Lines Up Candidates For Yahoo! Board 15 May 2008 04:41 GMT
... board. Earlier this month, he nominated three candidates to the board of biotech company Biogen Idec Inc. (nasdaq: Hedge fund managers had mixed views about the Icahn move. "You ...
- FDA Accepts NDA For Otsuka's Novel Hyponatremia Treatment 14 May 2008 14:38 GMT
... the only approved treatment for hospitalized patients with both hypervolemic hyponatremia and euvolemic hyponatremia Biogen Idec and Cardiokine are partnering on the selective V2 vasopressin receptor antagonist lixivaptan. Biogen ...
- Multiple Sclerosis Can Affect Children's IQ, Thinking Skills 14 May 2008 04:50 GMT
... American Academy of Neurology. The study was supported in part by a grant from Biogen-Dompè, a manufacturer of medications for MS. Need to cite this story in your essay, ...
- Investor Icahn eyes Yahoo 13 May 2008 23:46 GMT
... get financing. He has also nominated three board members in a challenge to drugmaker Biogen Idec Inc. after criticizing the company's sales process. ...
- Alnylam to Webcast Presentation at the Bank of America 2008 Health Care Conference 13 May 2008 23:33 GMT
... RNAi has enabled it to form major alliances with leading companies including Medtronic, Novartis, Biogen Idec, and Roche. To reflect its outlook for key scientific, clinical, and business initiatives, ...
- Pfizer CFO says not obliged to do mid-size deals 13 May 2008 22:52 GMT
... industry analysts have urged Pfizer to instead go after bigger prey, including companies like Biogen Idec (BIIB.O: ) that already have big-selling products on the market. "Last year we ...
- Childhood Multiple Sclerosis Impairs Cognitive Abilities 13 May 2008 22:19 GMT
... said, as quoted by Reuters. The study, supported in part by a grant from Biogen-Dompe, a manufacturer of medications fro MS, was published in the May 13, 2008 issue ...
- Is Harvard Just a Tax-Free Hedge Fund? 13 May 2008 19:54 GMT
... in the business of serving humanity through the creation and dissemination of knowledge, but Biogen claims to “transform scientific discoveries into advances in human healthcare.” That sounds pretty good, ...
- Optaros Assembles Syndication Application Widget to Increase Revenues for King Digital 13 May 2008 05:32 GMT
... than traditional build, buy or rent options. Optaros serves over 70 clients includŽing ABB, Biogen Idec, Gtech, McKesson, Merck/Serono, New York Times, Sony Pictures, Swisscom, and many others. For ...
- Activision, Biogen Idec, NVIDIA, and RealNetworks 13 May 2008 05:17 GMT
... Today's headlines includes Activision (ATVI) reporting a fourth-quarter profit, Biogen Idec (BIIB) urging share holders to reject director nominees, and NVIDIA (NVDA) and RealNetworks ...
1 - 25 of 83 next >
News by PR Newswire
|
